Nucleosomal chromatin

Nucleosomal chromatin is the fundamental structural unit of the eukaryotic genome, consisting of approximately 147 base pairs of DNA wrapped around an octamer of core histone proteins (H2A, H2B, H3, and H4) [Luger et al., Nature, 1997]. It serves as a dynamic platform for epigenetic regulation, where the post-translational modification of histone tails and the methylation of DNA dictate the accessibility of the genetic code to transcriptional machinery [Kornberg & Lorch, Cell, 1999]. In disease states, particularly oncology, the regulatory landscape of nucleosomal chromatin is often hijacked, leading to the silencing of tumor suppressor genes or the activation of oncogenic pathways through aberrant chromatin remodeling [Baylin & Jones, Nat Rev Genet, 2011]. Therapeutic strategies targeting this complex include small molecules that inhibit chromatin-modifying enzymes, such as histone deacetylases (HDACs) and DNA methyltransferases (DNMTs), which aim to reprogram the epigenetic state of the cell [Jones et al., Nat Rev Drug Discov, 2016]. Beyond its role in gene regulation, nucleosomal chromatin is a significant autoantigen in systemic lupus erythematosus (SLE) and is increasingly utilized as a liquid biopsy biomarker, as circulating nucleosomes in the blood can indicate high rates of cell turnover or specific disease pathologies [Holdenrieder et al., Crit Rev Clin Lab Sci, 2008].

Other names

NucleosomeChromatinHistone-DNA complex10-nm fiberEuchromatinHeterochromatin

Drugs targeting nucleosomal chromatin primarily function by modulating the epigenetic state of the genome. Histone deacetylase (HDAC) inhibitors prevent the removal of acetyl groups from histone tails, maintaining an open chromatin structure (euchromatin) to promote the expression of silenced tumor suppressor genes [Jones et al., Nat Rev Drug Discov, 2016]. DNA methyltransferase (DNMT) inhibitors reduce DNA methylation, preventing the recruitment of repressive chromatin-remodeling complexes [Baylin & Jones, Nat Rev Genet, 2011]. Additionally, cytotoxic agents like anthracyclines intercalate into the DNA within the nucleosome, disrupting the stability of the histone-DNA complex and inducing DNA damage responses [Pang et al., Nat Commun, 2013].